Wordt geladen...
A Liposomal Drug Platform Overrides Peptide Ligand Targeting to a Cancer Biomarker, Irrespective of Ligand Affinity or Density
One method for improving cancer treatment is the use of nanoparticle drugs functionalized with targeting ligands that recognize receptors expressed selectively by tumor cells. In theory such targeting ligands should specifically deliver the nanoparticle drug to the tumor, increasing drug concentrati...
Bewaard in:
| Hoofdauteurs: | , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Public Library of Science
2013
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3751880/ https://ncbi.nlm.nih.gov/pubmed/24009717 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0072938 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|